» Articles » PMID: 37984960

Predictors of Outcome in Sciatica Patients Following an Epidural Steroid Injection: the POiSE Prospective Observational Cohort Study Protocol

Overview
Journal BMJ Open
Specialty General Medicine
Date 2023 Nov 20
PMID 37984960
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Sciatica can be very painful and, in most cases, is due to pressure on a spinal nerve root from a disc herniation with associated inflammation. For some patients, the pain persists, and one management option is a spinal epidural steroid injection (ESI). The aim of an ESI is to relieve leg pain, improve function and reduce the need for surgery. ESIs work well in some patients but not in others, but we cannot identify these patient subgroups currently. This study aims to identify factors, including patient characteristics, clinical examination and imaging findings, that help in predicting who does well and who does not after an ESI. The overall objective is to develop a prognostic model to support individualised patient and clinical decision-making regarding ESI.

Methods: POiSE is a prospective cohort study of 439 patients with sciatica referred by their clinician for an ESI. Participants will receive weekly text messages until 12 weeks following their ESIand then again at 24 weeks following their ESI to collect data on leg pain severity. Questionnaires will be sent to participants at baseline, 6, 12 and 24 weeks after their ESI to collect data on pain, disability, recovery and additional interventions. The prognosis for the cohort will be described. The primary outcome measure for the prognostic model is leg pain at 6 weeks. Prognostic models will also be developed for secondary outcomes of disability and recovery at 6 weeks and additional interventions at 24 weeks following ESI. Statistical analyses will include multivariable linear and logistic regression with mixed effects model.

Ethics And Dissemination: The POiSE study has received ethical approval (South Central Berkshire B Research Ethics Committee 21/SC/0257). Dissemination will be guided by our patient and public engagement group and will include scientific publications, conference presentations and social media.

References
1.
Nagington A, Foster N, Snell K, Konstantinou K, Stynes S . Prognostic factors associated with outcome following an epidural steroid injection for disc-related sciatica: a systematic review and narrative synthesis. Eur Spine J. 2023; 32(3):1029-1053. DOI: 10.1007/s00586-023-07528-4. View

2.
White I, Royston P, Wood A . Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011; 30(4):377-99. DOI: 10.1002/sim.4067. View

3.
Oliveira C, Maher C, Ferreira M, Hancock M, Oliveira V, McLachlan A . Epidural Corticosteroid Injections for Sciatica: An Abridged Cochrane Systematic Review and Meta-Analysis. Spine (Phila Pa 1976). 2020; 45(21):E1405-E1415. DOI: 10.1097/BRS.0000000000003651. View

4.
Konstantinou K, Lewis M, Dunn K, Ogollah R, Artus M, Hill J . Stratified care versus usual care for management of patients presenting with sciatica in primary care (SCOPiC): a randomised controlled trial. Lancet Rheumatol. 2020; 2(7):e401-e411. PMC: 7323615. DOI: 10.1016/S2665-9913(20)30099-0. View

5.
Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D . Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011; 20(10):1727-36. PMC: 3220807. DOI: 10.1007/s11136-011-9903-x. View